Bio-Techne Corporation ( TECH) - Key Metrics
TECH Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | ? | ? | ? | ? |
| 2026Q2 | $1.90 | $0.24 | $0.53 | $0.49 |
| 2026Q1 | $1.84 | $0.25 | $0.18 | $0.14 |
| 2025Q4 | $2.05 | -$0.11 | $0.63 | $0.60 |
| 2025Q3 | $2.01 | $0.14 | $0.26 | $0.20 |
TECH Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | ? | ? |
| 2026Q2 | 32.80% | 60.20 |
| 2026Q1 | 32.59% | 56.63 |
| 2025Q4 | -70.07% | -112.71 |
| 2025Q3 | 55.69% | 102.12 |
TECH Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q3 | 0.95% | ? |
| 2026Q2 | 0.83% | 0.14% |
| 2026Q1 | 0.26% | 0.14% |
| 2025Q4 | 1.17% | 0.16% |
| 2025Q3 | 0.34% | 0.14% |
TECH
Price: $50.85
Dividend Yield: 0.66%
Forward Dividend Yield: 0.63%
Payout Ratio: 30.48%
Dividend Per Share: 0.32 USD
Earnings Per Share: 0.70 USD
P/E Ratio: 67.74
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 837800
Ebitda: 39.7 millionMarket Capitalization: 7.4 billion
Average Dividend Frequency: 4
Years Paying Dividends: 19
DGR3: 16.67%
DGR5: 10.00%
DGR10: 5.08%